We exist to improve the lives
of everyone affected by epilepsy

Trials for epilepsy medication by inhaler

5 August, 2003

Trials for the delivery of drugs for epilepsy, cystic fibrosis and chronic lung disease by inhaler within the next two years, according to a report in the Daily Mirror.

According to the inhaler system's manufacturer, Vectura, the delivery of drugs in a powder form using an inhaler results in the drug entering the bloodstream through the lungs, which would appear to be a more efficient method. Studies have shown that the medication starts working sooner and a lower dosage can be taken to achieve the same results as current methods of taking medication.

Aspirair inhaler productThe company have reported a successful trial of the inhaler to deliver drugs for erectile dysfunction.

Researcher Stephen Eason told The Mirror:

"It still has to go through more extensive trials. But we are pleased with the results so far, they are very encouraging."